Eyebright Medical Technology 的新型矫正镜片“Loong Crystal PR”获得中国批准。 Eyebright Medical Technology gets Chinese approval for its new corrective lens, "Loong Crystal PR."

眼光医学技术 已经得到了中国国家医疗产品管理局的批准 新的Phakic内眼镜“Loong Crystal PR” 获得了中国国家医疗产品管理局的批准。 Eyebright Medical Technology has received approval from China's National Medical Products Administration for its new Phakic intraocular lens, "Loong Crystal PR." 该镜片是为 -3.25D至 -18.00D之间有近视的成年人设计的,使用先进的丙烯酸材料,并配有零球形畸变设计,以改善视觉结果。 Designed for adults with myopia between -3.25D to -18.00D, the lens uses advanced acrylic material and features a zero spherical aberration design to improve visual outcomes. 该公司旨在提供高质量、安全的眼科解决方案。 The company aims to provide high-quality, safe ophthalmic solutions.